Inovio Pharmaceuticals In... (INO)
Inovio Pharmaceuticals Statistics
Share Statistics
Inovio Pharmaceuticals has 36.67M shares outstanding. The number of shares has increased by 41.51% in one year.
| 36.67M |
| 41.51% |
| 1.57% |
| 47.43% |
| n/a |
| 34,256 |
| 5.39% |
Short Selling Information
The latest short interest is 7.01M, so 19.11% of the outstanding shares have been sold short.
| 7.01M |
| 19.11% |
| 19.24% |
| 13.39 |
Valuation Ratios
The PE ratio is -0.46 and the forward PE ratio is -1.22. Inovio Pharmaceuticals's PEG ratio is 0.01.
| -0.46 |
| -1.22 |
| 228.26 |
| 0.2 |
| 0 |
| -0.48 |
| 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Inovio Pharmaceuticals.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.17.
| 2.77 |
| 2.77 |
| 0.17 |
| -114.15 |
| -113.47 |
| -632.05 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $1,625.04 |
| $-800,403.93 |
| 134 |
| 0 |
| n/a |
Taxes
| -107.15B |
| 99.9% |
Stock Price Statistics
The stock price has increased by -78.84% in the last 52 weeks. The beta is 1.31, so Inovio Pharmaceuticals's price volatility has been higher than the market average.
| 1.31 |
| -78.84% |
| 1.85 |
| 3.45 |
| 58.04 |
| 636,073 |
Income Statement
In the last 12 months, Inovio Pharmaceuticals had revenue of 217.76K and earned -107.25M in profits. Earnings per share was -3.95.
| 217.76K |
| -2.91M |
| -112.4M |
| -107.25M |
| -103.95M |
| -107.08M |
| -3.95 |
Balance Sheet
The company has 65.81B in cash and 11.87B in debt, giving a net cash position of 53.95B.
| 65.81B |
| 11.87B |
| 53.95B |
| -1,730.2B |
| 87.27B |
| 44.57B |
Cash Flow
In the last 12 months, operating cash flow was -104.08M and capital expenditures -487.83K, giving a free cash flow of -104.56M.
| -104.08M |
| -487.83K |
| -104.56M |
| -3.85 |
Margins
Gross margin is -1337.41%, with operating and profit margins of -51616.91% and -49254.27%.
| -1337.41% |
| -51616.91% |
| -49254269% |
| -49254.27% |
| -47735.19% |
| -51616.91% |
| -48019.06% |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for INO is $13, which is 513.2% higher than the current price. The consensus rating is "Hold".
| $13 |
| 513.2% |
| Hold |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jan 25, 2024. It was a backward split with a ratio of 1:12.
| Jan 25, 2024 |
| backward |
| 1:12 |
Scores
| -28.41 |
| 1 |